Access Structure

Vantro classifies each market using a standardized taxonomy based on procurement split, regulatory pathway type, and pricing framework. These profiles drive how the Expansion Score is weighted.

Regulatory-Gated

Entry primarily limited by regulatory complexity and approval timeline, regardless of procurement structure.

Criteria: Full dossier required or reliance pathway not established · Typical timeline >18 months

Tender-Dominant

Public sector accounts for >70% of procurement. Entry requires tender participation, government supplier registration, or public formulary listing.

Criteria: Public procurement share >70% · Tender cycle ≥12 months · UNICEF/Gavi eligibility common

Private-Led

Private sector drives majority of revenue. Insurance penetration and private hospital networks are primary channels.

Criteria: Private procurement share >50% · Insurance penetration >30% · Regulatory reliance pathway available

Price-Constrained

Ministry of Health sets reference or ceiling prices. Commercial pricing flexibility is limited across both public and private segments.

Criteria: MoH tariff schedule in force · Price differential public/private <20% · Reimbursement linkage to reference price

Hybrid Procurement

Balanced public/private split (40–60%). Entry strategy requires parallel engagement across both channels.

Criteria: Public procurement 40–60% · Both tender and private channels commercially viable · Mixed reimbursement landscape

Coverage

Vietnam · VMDF 510(k) · 12–18 mo Saudi Arabia · SFDA CE/510(k) · 6–12 mo Nigeria · NAFDAC · Public 90% India · CDSCO · Price-controlled UAE · MOHAP reliance · Private-strong Kenya · KEBS + PPB · Tender-driven

Market Intelligence Platform

Monitor and evaluate global health markets.

Continuous regulatory, pricing, procurement, and financial risk tracking for health product expansion across emerging and ASEAN markets.

Start free → View sample snapshot

15+

Markets tracked

Scoring dimensions

Live

Data updates

vantrohealth.com · snapshot

Market Access Snapshot

Analysis

Compare

🇵🇭

Philippines

Hybrid Procurement

Last verified: Feb 2026 · FDA Philippines · DOH · WHO

Expansion score

/ 100 composite

Regulatory

Timeline

Procurement

Pricing

Full registration pathway Local partner required 5% duty + VAT

Full 6-dimension breakdown available in detailed snapshot below.

Data from

🌐 WHO Global Health Observatory

🏦 World Bank Open Data

🏥 National Regulatory Authorities · 12 countries

Detailed market snapshot

Last verified: Feb 2026 · Sources: SFDA · WHO · NUPCO

vantrohealth.com · analysis

Vantro · Market Access Platform

Snapshot

Compare

Roadmap

Analysis output

🇸🇦

Saudi Arabia

Hybrid Procurement

Last verified: Feb 2026 · SFDA · WHO · NUPCO

Expansion score

/ 100 composite

Regulatory

Timeline

Procurement

Pricing

Local partner

Tax & customs

Regulatory phases

Phase 1

SFDA Classification

2–4 months

Phase 2

Device Registration

6–9 months

Phase 3

NHRA Digital Health

3–6 months

Procurement split

60%

Public · MOH/NUPCO

40%

Private sector

Risk flags

Local partnerRecommended

Data localizationMedium risk

Pathway typeCE / 510(k) reliance

Import duty5% · exemptions

Next actions

→Confirm SFDA registration pathway and class

→Review data localization requirements (PDPL)

→Initiate SFDA classification filing

How it works

Set up. Track. Decide.

Define your product profile once. Monitor any market continuously. Export when you're ready to move.

Vantro · Live preview

Coverage

Explore covered markets.

12 markets currently tracked

Scores composite across 6 verified dimensions · sources cited per record

What you get

Six scoring dimensions. Every tracked market.

A consistent, structured framework applied to every tracked market — calibrated to your product type and entry channel. All 6 dimensions weighted in composite score.

✓Structured signals for fast go/no-go evaluation

✓Grounded in verified country rules and primary sources

✓Comparable across markets, products, and entry channels

✓Each field cites its source and last-verified date

📋

Regulatory Pathway

Specific approval route given your existing clearances.

Reliance vs. full dossier

Which authority registers

QMS sufficiency

⏱

Timeline Estimate

Realistic range from submission to clearance.

Review range + bottlenecks

Pre-submission lead time

Distributor onboarding

🏛

Procurement Structure

How products are actually bought in this market.

Public vs. private split

Tender cycle timing

Insurance eligibility

💰

Pricing & Reimbursement

Whether public pricing is tariff-bound.

Ministry tariff applicability

Reference pricing signals

Public vs. private differential

🤝

Local Partner Requirements

Whether a local entity is legally required.

Mandatory vs. optional

Entity type required

Onboarding lead time

Monitor and evaluate global health markets.

Set up. Track. Decide.

Explore covered markets.

Six scoring dimensions. Every tracked market.

Free to start. Built to scale.

Start monitoring markets today.